This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
ProAssurance (PRA) Collaborates to Combat Opioid Epidemic
by Zacks Equity Research
ProAssurance (PRA) to coordinate with Sure Med Compliance for fighting the opioid epidemic in the United States.
ProAssurance (PRA) Q2 Earnings Beat Estimates, Improve Y/Y
by Zacks Equity Research
ProAssurance's (PRA) Q2 earnings benefit from significant growth across three operating segments.
ProAssurance (PRA) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
ProAssurance (PRA) delivered earnings and revenue surprises of 26.32% and 12.74%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
5 Solid Reasons to Hold ProAssurance in Your Portfolio
by Zacks Equity Research
Riding on five factors, ProAssurance (PRA) holds great potential to generate lucrative returns for investors.
Why Is ProAssurance (PRA) Down 16.2% Since Its Last Earnings Report?
by Zacks Equity Research
ProAssurance (PRA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Winners and Losers From Insurance Industry Post Q1 Results
by Tanuka De
We shortlist an array of insurance stocks for investors to either enrich their portfolio or offload post Q1 earnings season.
ProAssurance Hits 52-Week Low & Shares Fall 24%, Here's Why
by Zacks Equity Research
ProAssurance (PRA) shares have dragged from first quarter's earnings miss.
ProAssurance (PRA) Q1 Earnings Miss Estimates, Down Y/Y
by Zacks Equity Research
ProAssurance (PRA) suffers bottom-line deterioration and higher expenses in Q1. However, revenue rise and a solid uptick at Specialty P&C Insurance and Workers' Compensation segments are tailwinds.
Avoid ProAssurance (PRA), Check These Top 3 Insurers Instead
by Zacks Equity Research
We have narrowed down to three bullish stocks to leverage investors' portfolios with a suggestion to avoid ProAssurance (PRA) at present.
Why Is ProAssurance (PRA) Down 3.2% Since its Last Earnings Report?
by Zacks Equity Research
ProAssurance (PRA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
New Strong Sell Stocks for March 9th
by Zacks Equity Research
Here are 4 stocks added to the Zacks Rank #5 (Strong Sell) List today:
ProAssurance (PRA) Q4 Earnings & Revenues Miss Estimates
by Zacks Equity Research
Lower premiums hamper ProAssurance's (PRA) fourth-quarter results.
ProAssurance Grows Inorganically Led by Strong Capital Level
by Zacks Equity Research
ProAssurance's (PRA) organic and inorganic initiatives have favored the top line. Healthy balance sheet also remains a positive.
RenaissanceRe Suffers from Catastrophe Loss, High Leverage
by Zacks Equity Research
RenaissanceRe's (RNR) cat loss and high expenses are weighing on the stock's earnings performance.
Allstate Continues to Prosper Despite Significant Cat Loss
by Zacks Equity Research
Allstate (ALL) continues to post underwriting profitability despite significant catastrophe losses.
ProAssurance (PRA) Q3 Earnings & Revenues Beat Estimates
by Zacks Equity Research
ProAssurance's (PRA) strong third-quarter results were primarily driven by premium growth.
New Strong Sell Stocks for October 25th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
ProAssurance to Incur $7.5M Catastrophe Loss From Hurricanes
by Zacks Equity Research
ProAssurance (PRA) to incur weather-related losses because of exposure to Lloyds Syndicate.
Should Investors Avoid ProAssurance (PRA) Stock Now?
by Zacks Equity Research
It is a wise decision to avoid investing in ProAssurance (PRA) stock now as the company is suffering from weak investment portfolio, volatility in premium retention as well as rising expenses.
Why Is ProAssurance (PRA) Down 10.3% Since the Last Earnings Report?
by Zacks Equity Research
ProAssurance (PRA) reported earnings about a month ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks Industry Outlook Highlights: Aspen Insurance, ProAssurance, Markel Corporation and Atlas Financial
by Zacks Equity Research
Zacks Industry Outlook Highlights: Aspen Insurance, ProAssurance, Markel Corporation and Atlas Financial
P&C Insurers' Prospects Look Bleak, Rate Move Makes No Sense
by Kalyan Nandy
While there is almost no support from a relatively range-bound interest rate environment, this industry segment is struggling with a number of headwinds.
ProAssurance (PRA) Q2 Earnings Beat, Revenues Miss Estimates
by Zacks Equity Research
ProAssurance Corp's (PRA) second-quarter revenues missed estimates on lower net investment income.
ProAssurance Grows on Buyouts, Financial Health Strengthens
by Zacks Equity Research
The Birmingham-based insurer, ProAssurance Corporation (PRA) operates as a holding company for many property and casualty insurance firms
Why Should You Still Hold Onto Chubb Limited (CB)?
by Zacks Equity Research
Shares of Chubb Limited (CB) have outperformed the Zacks categorized Property and Casualty Insurance industry, quarter to date. The estimates have also been revised upward for last 30 days.